Penn Cancer Innovation
@pc3innovation
The Penn Center for Cancer Care Innovation (PC3I) works at the nexus of research and practice to create, test, and scale solutions to transform #cancercare.
ID: 1245709158755770368
http://pc3i.upenn.edu 02-04-2020 13:47:11
1,1K Tweet
1,1K Followers
251 Following
#PC3IatASCO: PC3I's Allie Allison Barz Leahy & Haley Newman analyzed patient & caregiver-reported #financialtoxicity (FT) outcomes for #pediatric pts receiving CAR T therapy & found high prevalence of FT at time of infusion. #ASCO25 ASCO meetings.asco.org/abstracts-pres… pc3i.upenn.edu/news/pc3i-pres…
#PC3IatASCO: Melina Marmarelis, Charu Aggarwal, MD, MPH, FASCO & team used an EMR-based nudge for #NSCLC molecular testing at time of 1st post-operative visit. Findings showed the nudges increased rate of #moleculartesting in patients. #ASCO25 #LungCancer #LCSM ASCO meetings.asco.org/abstracts-pres…
#PC3IatASCO: Emily Ko, Lakeisha Mulugeta-Gordon, MD MSHP & Carmen Guerra evaluated implementation of a patient-ambassador program to provide #GynecologicOncology clinical trial awareness & knowledge for patients. #ASCO25 ASCO meetings.asco.org/abstracts-pres… pc3i.upenn.edu/news/pc3i-pres…
#PC3IatASCO: Susan Domchek w/ PC3I's Kate Rendle, PhD (she/her) & Peter Gabriel implemented #nudges to increase #genetictesting for diverse populations of patients at risk for #breastcancer and #ovariancancer across Penn Medicine sites. #ASCO ASCO meetings.asco.org/abstracts-pres…
#PC3IatASCO: Gabriel Aleixo, Ramy Sedhom, MD, FASCO, Efrat Dotan MD, & Ravi B. Parikh evaluating implementation of the Practical #Geriatric Assessment & resulting #chemotherapy dose modification among older adults with #cancer. #ASCO25 ASCO meetings.asco.org/abstracts-pres… pc3i.upenn.edu/news/pc3i-pres…
Huge congrats to my friend Dr. Gabriel Aleixo (Gabriel Aleixo) on presenting PACE-70 at #ASCO25 — the first real-world study of the Practical Geriatric Assessment (PGA) in community oncology! 🧓🏽📋🏥 📊 In 3 Penn-affiliated sites, PACE-70 is: — Measuring PGA uptake & barriers —
#ASCO25 ASCO has been incredible - breadth and depth of research presented by Penn Cancer Innovation Penn Medicine - Abramson Cancer Center Penn Medicine Penn Medicine MD Here is a quick recap! tinyurl.com/49yvc65f #LCSM #QoL #AI #FinancialToxicity Ronac Mamtani Lynn Schuchter Melina Marmarelis
Several young celebrities announced #breastcancer diagnoses in the past year - reaffirming the rising rates among women under 50. PC3I's Lola Fayanju (she/her, [email protected]) spoke w/ NBC News, recommending young women with symptoms go to centers experienced in breast imaging. nbcnews.com/health/womens-…
A study led by PC3I's Kimberley Lee, MD MHS explored oncologists' perceptions of gonadotropin-releasing hormone agonists as ovarian function suppression for treatment of early-stage #breastcancer. Findings showed a need for guidance in determining menopausal status. pubmed.ncbi.nlm.nih.gov/40461861/
A project led by PC3I Program Director Lola Fayanju (she/her, [email protected]) is combining the Best Case/Worst Case framework w/ the comprehensive geriatric assessment to increase shared decision-making conversations & improve communication & care for older adults w/ #cancer. pc3i.upenn.edu/our-work/proje…
A study led by PC3I Faculty Kate Courtright measured Goal-Concordant Care, the highest quality of care, using clinical notes in pts' medical records & found this method of measurement to be feasible & scalable. Findings published in JAMA Network Open jamanetwork.com/journals/jaman…
Patients with prior authorization requirements are more likely to have their access to #chemotherapy interrupted-a 10 day delay on average. PC3I Faculty Michael Anne Kyle spoke with The New York Times on the effects of health insurers denying drug claims for patients. nytimes.com/2025/07/18/hea…